Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-04-2024 | Piperacillin | Case report

Piperacillin/tazobactam

Symmetrical drug-related intertriginous and flexural exanthema

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Lyons D, et al. Symmetrical drug-related intertriginous and flexural exanthema: a rare and unusual drug eruption. BMJ Case Reports 17: Jan 2024. Available from: URL: https://dx.doi.org/10.1136/bcr-2023-258348 Lyons D, et al. Symmetrical drug-related intertriginous and flexural exanthema: a rare and unusual drug eruption. BMJ Case Reports 17: Jan 2024. Available from: URL: https://dx.doi.org/10.1136/bcr-2023-258348
Metadata
Title
Piperacillin/tazobactam
Symmetrical drug-related intertriginous and flexural exanthema
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56533-8

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Cimicifuga